Skip to content

Clinical trials

Respiratory Tract Diseases trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Not applicable Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20052
20082
20094
20101
20112
20121
20138
20145
20153
20165
20176
20183
20192
20203
20214
20228
20235
20246
20258
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55
Unknown status15
Recruiting14
Not yet recruiting3
Active, not recruiting2
Terminated2
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
FDA Office of Orphan Products Development4
Universidade Metodista de Piracicaba3
VA Office of Research and Development3
Ain Shams University2
Nantes University Hospital2
National Center for Research Resources (NCRR)2
Olympus Corporation of the Americas2
The First Affiliated Hospital of Guangzhou Medical University2
University of California, Los Angeles2
Albert Einstein College of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases94
Lung Diseases28
Pulmonary Disease, Chronic Obstructive16
Rare Diseases14
Asthma11
Lung Diseases, Obstructive11
Respiration Disorders10
Cystic Fibrosis8
Neoplasms8
Genetic Diseases, Inborn7

Trials

Showing 76 to 94 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.